The partners intend to combine medical device maker LifeTech's expertise in China with ABG's global healthcare investment profile.
China-based medical device manufacturer LifeTech Scientific partnered US-based private equity firm Ally Bridge Group (ABG) yesterday to launch a medical technology fund of undisclosed size.
The fund will help portfolio companies expand in China and is intended to combine LifeTech’s expertise in the country, where an expedited drug approval process was approved in October 2017, with ABG’s international investment profile.
LifeTech received funding from ABG in 2011, and the latter facilitated medical technology producer Medtronic’s $66.2m investment in LifeTech in…
